Stem Cells 2021

Sep 06-07, 2021


Online Webinar

Welcome message

LexisConferences conferences cordially invite you to present your innovative work ideas and interchange ideas in the 6th Annual congress on Cell sciences, Stem Cells and Regenerative Medicine to be held from September 06-07, 2021 | Webinar.

Stem cells 2021 present a platform where experts, researchers, professionals, and students from across the globe gather and share their innovative ideas through presentations and oral talk. The conference provides an opportunity to enhance and explore knowledge and discuss queries along with challenges in the respective field.


About conference

Aim- LexisConferences organizing Stem Cells 2021 Webinar will provide a common platform to leaders in research, industrial experts, and trainees to share innovative ideas and new visions in the respective fields leading to the development of cutting edge advanced next generation of stem cell technologies such as regenerative medicines.


Why attend

Stem cells 2021 will create an ideal platform to share and nitrify knowledge, in-depth learning related to the latest research work in the stem cells field. Debate to optimize gaps and priorities leading to the development of outstanding next-generation stem cell technologies and measure future aspects, updates related to the stem cells field. The event provides an opportunity to interact with well-renowned speakers and meet industry experts.


Benefits of attending

Stem cells 2021 conference brings together experts and trainees to share new visions and innovative ideas. Trainees and students have the opportunity to gain in-depth knowledge related to the latest research work and have a discussion round for any questions.

Target audience

Keynote Speakers | Renowned Speakers | Eminent Personalities | Association Heads | Directors | CEO | Organization | Institution Heads | Stem Cell Laboratory Heads | Researchers | Post-Doc | Students


We invite all experts of field across the globe to attend Stem Cells 2021 to be held from September 06-07, 2021 | Webinar after the success of 5th conference to give presentations and discuss aspects of future advancement in stem cells field and students for e-poster presentation, oral talks along. Conference also includes abstract submission and symposium. In recent years, stem cells lead to a promising field of advancement in research and market area to provide cutting-edge technology. Stem cells possess enormous potential to differentiate into other types of cells providing a great opportunity for reparative therapies area. Stem cells are somatic (capable of self-renewal) and embryonic (forms different types of cells).  

The potential of stem cells leads to the development of the field. Biological tissue engineering provides a research field in regenerative medicine area finding applications to restore damaged tissues and organs by enhancing the body’s repair mechanism following the advancement of the field through disease-specific treatment and exploiting stem cells properties for improving survival rate.


Market analysis

The stem cells market is continuously increasing mainly due to increased awareness regarding researches and therapies along with increased funding from both government and private sectors. The global market of stem cells has a CAGR of 36.52% from 2017-2021 and is dominated by the USA primarily (13.9% CAGR) followed by Europe (13.4% CAGR). Asia-Pacific shows the highest growth in the stem cells market. North America contributes around 77.45 of the total US market.

Stem cells help in the fast growth of the oncology disorder segment. Research areas leading to the evolution of new therapies such as regenerative therapies, use of induced pluripotent stem cells as an alternative to embryonic stem cells contribute to high revenue share. High totipotency and indefinite lifespan of stem cells are the main advantages in market development.

Top companies competing in the market for stem cell products are Thermo Fischer Scientific, Qiagen NV, Sigma Aldrich, Becton, Dickinson, and company and stem cell technologies.

Tracks and Sub tracks 

Track 1- Stem cells

Stem cells are a totipotent undifferentiated mass of cells that can be either pluripotent i.e. forming any type of cell or multipotent i.e. confined to a more constrained variety of cells. Stem cells offer properties like high totipotency and indefinite lifespan thus finding use in regenerative medicines, cancer therapy, etc.

Track 2- Tissue engineering

The technique is used for repairing damaged or broken tissues and organs to restore activity. It involves the use of a variety of strategies for modification or choreographing of organic functions and chemical processes. Scaffolds Tissue Engineering designed for transplantation and support in the tissue engineering process.

  • Trends In Tissue Engineering

  • Applications In Tissue Engineering

  • Scaffolds In tissue engineering

  • Tissue Repair And Regeneration

  • Stem Cells Progress in In situ Revascularization And Grafting

Track 3- Regenerative medicine

Property of stem cells used to Repair Tissues and organs to regain lost activity and reparative mechanism. It provides a promising field in therapies and treatment such as the use Of Umbilical Cord Blood for treatment.  

  • Scaffolds in regenerative medicine

  • Repair mechanism of cell

  • Pathways for repair mechanism

  • New technologies or processes in regenerative medicine production

Track 4- Immunology

Stem cells therapy involves cellular form where healing efficacy mainly depends upon potency, quality and quantity (purity) of stem cells. Bone marrow transplantation therapies are widely used followed by those derived from umbilical cord blood.

Track 5- Advances in stem cells and their niches

Foundational microorganism interacts with immature microorganisms to determine cell fate. New doors are opened for the pharmaceutical organizations to create novel medicine. Single cells were examined to study cell behavior and separation process.

  • Germline

  • Molecular mechanisms of GSC maintenance and activity

  • Physical attachment of GSCs to cap cells

  • Systemic signals regulating GSCs

  • Stem cell aging

Track 6- Repair and regeneration

Stem cells providing a promising field of advancement due to increased demand and finding application in the treatment of disorders such as hematological, neurological and organ transplant. Stem cells restore the activity of damaged tissues and organs due to the totipotency of cells. Stem cells have great potential in the treatment of diseases such as stroke, Cohn’s disease, traumatic brain injury, Alzheimer’s disease, myocardial infarction, infertility, diabetes, and etc.

  • Reprogramming And Creating Stem Cells

  • Regenerative Approaches With Nanoparticles

  • Decentralization

  • Advanced Developments In Artificial Organ System

Track 7- Stem cells beat Covid-19

Stem cells emerging as a new possible treatment technique by use of their secreted extracellular vesicles in attenuating inflammation and regenerate damaged lungs in patients of COVID-19.

Track 8- Disease and treatment

Stem cells are used to treat diseases by means of exploiting their properties. Induced pluripotent stem cells are used as an alternative to embryonic stem cells. Stem cells are used to treat cancer thus securing the oncology field's major growing area in today’s era. Blood stem cells transplantation is extensively used to treat ailments caused mainly due by changing lifestyles.

Track 9- Novel stem cell technologies

The field of research in novel technologies for therapeutic or treatment purposes is expanding in the recent era involving the use of multiple fields like Molecular Biology, Biotechnology, Biochemistry,  Bio-Imaging etc. Properties of stem cells offer effective treatment strategies and goals.

  • Assay Marks Excellence in Cell Line Quality

  • Stem Cell Embryonic Vascular Development

  • Develop sources for stem cells

Track 10- Computational biology

Computational biology multidisciplinary field related to computer software systems to study cells at the molecular level. It provides information regarding regulatory genes, transcriptional and translational circuits. Bioinformatics helps to study disease and repair mechanisms at a molecular level for effective treatment strategy.

Track 11- Tumor cell science

Cancer cells originating in tissues at the cellular level or stem cell level can lead to malignancy. Effective treatment of cancer involves stem cells transplantation to restore tissue activity and repair mechanism. Cancerous cells are specialized mainly in evading the host immune system as working independently of signals from other cells.

Track 12- Cell and organ regeneration

Regenerative medicine is an emerging field of medical technology for the treatment of ailments that are specialized mainly in evading the host immune system. Drug discovery and studies at the molecular level and cellular level in stem cells lead to the development of high-throughput technologies of disease treatment.

  • Bio fabrication And Bone Tissue

  • Regeneration Manufacturing Challenges for Regenerative Medicine

  • Nanotechnology In The Regeneration of Complex Tissues

  • Regenerative Medicine Market

  • Stem Cell Pellets/Sheets In Regenerative Therapy

  • Hair Follicle Stem Cells In Regeneration

Track 13- Drugs and clinical development

Stem cells hold a promising area for working as powerful tools in biomedical studies. Stem cells properties have the capacity to provide high-throughput techniques in curing ailments.

  • Recent Developments Clinical Trials of Stem Cell Therapy

  • Screening New Compounds for Identifying More Effective Medicines

  • Currently Viable Companies Challenges And Status

  • Funding And Regulatory Challenges

Track 14- Stem cell apoptosis and signal translation

Apoptosis is programmed cell death which hampers re- establishment by itself and multiplication of foundational micro-organisms.

The foundational micro-organisms amount is thusly a concord between ones misplaced to separation/apoptosis and those increased through multiplication. Apoptosis of immature microorganisms is generally a dynamic technique that leads to adjustments because of herbal situations

Track 15- Stem Cell Embryology

Embryonic stem and Germ Lines recovered from blastula follow autonomous development and Embryonic Gonad Cells have the potential to differentiate in more than one type of cells. Stem cells are used in the treatment of infertility.

  • Molecular Alterations During Female Reproductive Aging

  • Role of Sperm DNA Integrity In Fertility

  • Fertilization And Infertility

  • Embryo Implantation

  • Role of Macrophages In The Placenta

  • Factors of Human Implantation

Track 16- Bio-Banking and Bio-Markers

The storage of stem cells especially umbilical cord stem cells in the bio-bank leads to new technologies for preservation and maintaining their viability for years.

Biomarkers are especially obtained from micro-organisms. Markers are genes and protein products useful for the categorization and isolation of embryonic stem cells to reveal their differentiation state using antibody-based strategies. They are used in drug discovery studies and therapeutic studies.

Dr Pradeep Mahajan
Chairman Managing Director
StemRx Bioscience Solutions Pvt Ltd


Dr. Pradeep Mahajan is the Chairman & Managing Director of StemRx Bioscience Solutions Pvt. Ltd. Mumbai—one of the leaders in therapeutic applications of Regenerative Medicine. Aside from being a general and uro-surgeon, Dr. Mahajan has undergone trainings at the national and international levels in Regenerative medicine and Cell-based therapies, through which he aims to find solutions to a wide spectrum of health conditions. Through various collaborations to conduct research in Regenerative Medicine, import medical devices, investigational drug products, etc. globally with the required approvals, StemRx aims to further advance in the healthcare sector and enable individuals live a healthier life by utilizing the inherent healing potential of the body.

Researches :

  • Therapeutic applications of Regenerative Medicine
  • Regenerative medicine and Cell-based therapies
Kazi Ahsan Jamil
Network Ambassador
Kagoshima University


Kazi Ahsan Jamil at present is working as a faculty member at the Universiti Teknologi MARA, Dental faculty, Malaysia. He has served as a faculty member in the Department of human anatomy (1998-2003), Fac Medicine, Kagoshima University, Japan. He has also worked at the National University of Singapore (NUS, 2003-2008), has a Graduate degree in Bachelor of Dental Sugary from University of Dhaka, Bangladesh in 1987 and has a PhD in Dental Science from Kagoshima University, Japan in 1999. In teaching his main interests are neuroscience and neuro-anatomy. His main research interests include molecular neuroscience, neuro-modulation by natural products, pain and drug addiction. He is the Editor-in-Chief of two journals; Journal of Biosciences and Medicines and Journal of Advances in Molecular Biology (JAMB). He is the Network Ambassador for Kagoshima University, Kagoshima, Japan.

Researches :

  • Molecular Neuroscience
  • Neuro-anatomy
Dr CP Abdolrasoul Aleezaadeh
Associate Expert
Green Lake University



Prof. Dr. C.P Abdolrasoul Aleezaadeh completed his Post Doctorate in (Psychology) at Approach of Applied Clinical Cognitive Neuropsychology from the USA. Prof. Dr. Aleezaadeh Completed his Ph.D. Degrees in Psychology in the USA. He completed his Master's Degree in Clinical Psychology at I. R. of the IRAN, Bachelor's Degree in General Psychology at I. R. of the IRAN, Bachelor's Degree in Homeopathic Medicine - I.R of IRAN (Berkeley International University - the USA) and, Advanced Curriculum in Traditional Medicine at W.M.C - I.R of IRAN (Tibbia College Gujranwala - Pakistan). Also, he has five Certificates/Documents in e-Marketing, Marketing, Marketing Management, Sales Management and, Sales Management (A Global Perspective) at Cavendish Caramad Institute - I.R of IRAN (Cavendish College - the UK) and, Instructor of first aid (initial, complementary, and specialized). He is Full Expert International Faculty Professorship Member in the Brooklyn Central University, the USA, Associate Expert International Faculty Professorship Member in the University of Pacific Albion, the USA and, Associate Expert International Faculty Professorship Member in Green Lake (Green Lake) University, the USA. Now he is working as an Assistant Professor at P.N.U and, U.A.S.T Universities; I.R. of IRAN.

Researches :

  • Cognitive Neurosciences
  • Biotechnological Researches
Dr Jenny Wang
Group Leader
Childrens Cancer Institute


Dr Jenny Wang is a Senior Lecturer and ARC Future Fellow at the Faculty of Medicine, UNSW Australia and a Group Leader of Cancer and Stem Cell Biology at Children's Cancer Institute. She received her PhD in Molecular Biology and Biochemistry from Macquarie University, and undertook postdoctoral training with A/Prof Scott Armstrong in cancer stem cell biology at Harvard Medical School/Harvard Stem Cell Institute in Boston USA (2005–2011). The main focus of her laboratory is to develop novel therapies targeting malignant stem cells that are often resistant to chemotherapy and that are now believed to be the root cause of treatment failure and relapse in cancer.

Researches :

  • Cancer Cell Biology
  • Regenerative Medicine (incl. Stem Cells and Tissue Engineering)
Dr Alireza Heidari
American International Standards Institute


Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Distinguished Professor and Academic Tenure of Chemistry and also Enrico Fermi Distinguished Chair in Molecular Spectroscopy at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than five hundred reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI), Medline/PubMed and Scopus Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Luxembourg, Romania, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Indonesia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Kingdom of Saudi Arabia, Jordan, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than one thousand reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international and peer–reviewed journals, books and publishers. Hitherward, he is a member of more than five hundred reputed international academic–scientific–research institutes around the world. It should be noted that he is currently the President of the American International Standards Institute (AISI), Irvine, California, USA and also Head of Cancer Research Institute (CRI) and Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.

Researches :

  • Cancer Research
Dr Ahmed G Hegazi
National Commission for Microbiology


Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the National Research Center, Egypt. Prof. Hegazi received his master’s degree in 1979 and his PhD in 1981. Hegazi's research work has been focused lately on bee products and their therapeutic effects.Hegazi organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He has published 222 scientific papers and articles in national and international journals. He also served on the board of multiple national and international scientific journals.

Researches :

  • Immunology
Alejandro De La Parra-Solomon
Senior Partner
World Academy of Medical Sciences


Mr. De la Parra is an entrepreneur focused on Information Technology, Education and Health. He is creative, results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra serves as COO and Co-founding Partner at The Solomon Brokerage Firm and leads as CEO at Mass Media Division and at De la Parra Mobile Solutions. He is the former President & Co-founder of PetroM Renewable, and served as Vice President of Operations & Strategy at PetroM Corp across all of its divisions, including PetroM Logistics. He is the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra is the former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, a member of the WAMS Executive Council (WAMS Executive Board), a member of the WAMS Education & Training Board (ETB), a member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & is also a Senior Partner at WAMS, The World Academy of Medical Sciences. He is also an Advisory Board member, functioned as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of Singularity University and of OpenExo.

Researches :

  • Regenerative Medicine

Program Overview

Our Collaborations, Sponsors, Media Partners